Dr. Matthew Johnson Benefits of Psychedelics
Psychedelic therapy is moving from fringe to frontline. Dr. Matthew Johnson of Johns Hopkins shares how psilocybin and other psychedelics are showing promise in treating depression, addiction, and cancer-related distress. With fast-acting, long-lasting effects and growing FDA interest, Johnson believes psychedelic medicine may soon become a transformative branch of mental health care.